Stockreport

Mass General Brigham Joins Better Therapeutics in Real World Evidence Study Collaboration

Better Therapeutics, Inc.  (BTTX) 
PDF Open-label, randomized, controlled real world study will evaluate use of BT-001, a prescription digital therapeutic (“PDT”) designed to treat type 2 diabetes by changing [Read more]